These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8856573)

  • 1. Interferon-alpha for viral hepatitis.
    Jonas MM
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):93-106. PubMed ID: 8856573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic non-A non-B hepatitis treated with interferon].
    Bjøro K; Schrumpf E; Elgjo K; Nordgård K
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1346-8. PubMed ID: 2111053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.
    Haria M; Benfield P
    Drugs; 1995 Nov; 50(5):873-96. PubMed ID: 8586031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis.
    Saracco G; Touscoz A; Durazzo M; Rosina F; Donegani E; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Solinas A
    J Hepatol; 1990 Nov; 11(3):339-43. PubMed ID: 2127054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of interferon in the treatment of viral hepatitis.
    Wong DK; Heathcote J
    Pharmacol Ther; 1994 Aug; 63(2):177-86. PubMed ID: 7809178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
    Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
    Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
    Antonelli G; Currenti M; Turriziani O; Dianzani F
    J Infect Dis; 1991 Apr; 163(4):882-5. PubMed ID: 1901335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic hepatitis treated with alpha-interferon].
    Michael M
    Orv Hetil; 1992 Jul; 133 Suppl 1():63-5. PubMed ID: 1630805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis B, delta related liver disease and non-A non-B hepatitis.
    Jafri SM
    J Pak Med Assoc; 1989 Jun; 39(6):162-7. PubMed ID: 2475648
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
    Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B
    Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies.
    Schvarcz R; Weiland O; Wejstål R; Norkrans G; Frydén A; Foberg U
    Scand J Infect Dis; 1989; 21(6):617-25. PubMed ID: 2482536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant alpha 2c-interferon therapy in fulminant viral hepatitis.
    Sánchez-Tapias JM; Mas A; Costa J; Bruguera M; Mayor A; Ballesta AM; Compernolle C; Rodés J
    J Hepatol; 1987 Oct; 5(2):205-10. PubMed ID: 3693864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of treatment for chronic viral hepatitis using recombinant interferon alpha].
    Hopf U; Küther S; König V; Heuft HG; Berg T; Huhn D
    Dtsch Med Wochenschr; 1994 Jul; 119(27):961-4. PubMed ID: 8026311
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic viral hepatitis anno 1990.
    Schalm SW
    Scand J Gastroenterol Suppl; 1990; 178():111-8. PubMed ID: 2126146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of recombinant interferon alpha on nutritional status and growth pattern in children with chronic viral hepatitis.
    Gottrand F; Michaud L; Guimber D; Ategbo S; Dubar G; Turck D; Farriaux JP
    Eur J Pediatr; 1996 Dec; 155(12):1031-4. PubMed ID: 8956939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis C patients treated with interferon in Taiwan.
    Hou C; Chuang WL; Yu ML; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY
    Scand J Gastroenterol; 2000 Dec; 35(12):1288-93. PubMed ID: 11199369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.
    di Cesare E; Previti M; Russo F; Brancatelli S; Ingemi MC; Scoglio R; Mazzù N; Cucinotta D; Raimondo G
    Dig Dis Sci; 1996 Aug; 41(8):1672-7. PubMed ID: 8769300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.